Search Results - "Huang, Hsueh‐Cheng"
-
1
Short‐duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial
Published in Hepatology (Baltimore, Md.) (01-02-2017)“…Direct‐acting antiviral agents (DAAs) represent the standard of care for patients with hepatitis C virus (HCV) infection. Combining DAAs with different…”
Get full text
Journal Article -
2
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure
Published in Hepatology (Baltimore, Md.) (01-12-2017)“…People with hepatitis C virus (HCV) infection who have failed treatment with an all‐oral regimen represent a challenging treatment population. The present…”
Get full text
Journal Article -
3
Cyclic-Disulfide-Based Prodrugs for Cytosol-Specific Drug Delivery
Published in Angewandte Chemie International Edition (15-12-2014)“…The cytosolic conversion of therapeutically relevant nucleosides into bioactive triphosphates is often hampered by the inefficiency of the first…”
Get full text
Journal Article -
4
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Published in Annals of internal medicine (01-11-2016)“…Hepatitis C virus (HCV) infection is common in persons who inject drugs (PWID). To evaluate elbasvir-grazoprevir in treating HCV infection in PWID. Randomized,…”
Get full text
Journal Article -
5
Novel intramolecular aminohydroxylation toward the syntheses of 2′-amino-2′-ethynyl nucleosides
Published in Tetrahedron letters (25-05-2021)“…[Display omitted] •Tertiary amino nucleoside via tethered aminohydroxylation.•Diastereospecificity.•Nucleosides bearing ethynyl/amino at the C2′ position…”
Get full text
Journal Article -
6
Ube3a unsilencer for the potential treatment of Angelman syndrome
Published in Nature communications (08-07-2024)“…Deletion of the maternal UBE3A allele causes Angelman syndrome (AS) ; because paternal UBE3A is epigenetically silenced by a long non-coding antisense (…”
Get full text
Journal Article -
7
Concise syntheses and HCV NS5B polymerase inhibition of (2′R)-3 and (2′S)-2′-ethynyluridine-10 and related nucleosides
Published in Bioorganic & medicinal chemistry letters (01-12-2017)“…[Display omitted] (2′R)-Ethynyl uridine 3, and its (2′S)-diastereomer 10, are synthesised in a divergent fashion from the inexpensive parent nucleoside. Both…”
Get full text
Journal Article -
8
Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase
Published in Journal of medicinal chemistry (26-01-2012)“…Starting with the indole-based C-3 pyridone lead HCV polymerase inhibitor 2, extensive SAR studies were performed at different positions of the indole core…”
Get full text
Journal Article -
9
A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors
Published in Journal of medicinal chemistry (08-03-2012)“…Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure–activity relationship (SAR) investigations of the indole N-1 benzyl moiety…”
Get full text
Journal Article -
10
Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics
Published in Bioorganic & medicinal chemistry (01-01-2014)“…HCV infections are the leading causes for hepatocellular carcinoma and liver transplantation in the United States. Recent advances in drug discovery have…”
Get full text
Journal Article -
11
Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase
Published in Bioorganic & medicinal chemistry (01-04-2013)“…The characterization of HCV genome has identified various vital functional proteins involved in the life cycle of hepatitis C virus. This has resulted in many…”
Get full text
Journal Article -
12
Discovery of an irreversible HCV NS5B polymerase inhibitor
Published in Bioorganic & medicinal chemistry letters (15-12-2013)“…The discovery of lead compound 2e was described. Its covalent binding to HCV NS5B polymerase enzyme was investigated by X-ray analysis. The results of…”
Get full text
Journal Article -
13
A novel hepatitis C virus NS5B polymerase assay of de novo initiated RNA synthesis directed from a heteropolymeric RNA template
Published in Methods in molecular biology (Clifton, N.J.) (2013)“…The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase is essential for viral replication and a clinically validated antiviral target. Discovery of HCV…”
Get more information
Journal Article -
14
5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors
Published in Bioorganic & medicinal chemistry letters (01-05-2012)“…Based on a previously identified HCV replication (replicase) inhibitor 1, SAR efforts were conducted around the pyrimidine core to improve the potency and…”
Get full text
Journal Article -
15
Novel substituted pyrimidines as HCV replication (replicase) inhibitors
Published in Bioorganic & medicinal chemistry letters (15-01-2012)“…Compound 1 was identified as a HCV replication inhibitor from screening/early SAR triage. Potency improvement was achieved via modulation of substituent on the…”
Get full text
Journal Article -
16
Synthesis and SAR of geminal substitutions at the C5′ carbosugar position of pyrimidine-derived HCV inhibitors
Published in Bioorganic & medicinal chemistry letters (15-11-2012)“…The installation of geminal substitution at the C5′ position of the carbosugar in our pyrimidine-derived hepatitis C inhibitor series is reported. SAR studies…”
Get full text
Journal Article -
17
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors
Published in Bioorganic & medicinal chemistry letters (01-09-2012)“…Introduction of a nitrogen atom into the benzene ring of a previously identified HCV replication (replicase) benzothiazole inhibitor 1, resulted in the…”
Get full text
Journal Article -
18
Cyclic-Disulfide-Based Prodrugs for Cytosol-Specific Drug Delivery
Published in Angewandte Chemie (15-12-2014)“…The cytosolic conversion of therapeutically relevant nucleosides into bioactive triphosphates is often hampered by the inefficiency of the first…”
Get full text
Journal Article -
19
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors
Published in Bioorganic & medicinal chemistry letters (01-08-2012)“…Introduction of nitrogen atom into the benzene ring of a previously identified HCV replication (replicase) benzofuran inhibitor 2, resulted in the discovery of…”
Get full text
Journal Article -
20
Discovery of SCH 900188: A Potent Hepatitis C Virus NS5B Polymerase Inhibitor Prodrug As a Development Candidate
Published in ACS medicinal chemistry letters (13-03-2014)“…Starting from indole-based hepatitis C virus (HCV) NS5B polymerase inhibitor lead compound 1, structure modifications were performed at multiple indole…”
Get full text
Journal Article